ERASCA
Erasca develops oncology drugs intended to provide precision oncology options. The company's drugs are being developed through multiple discovery programs for undisclosed targets that are biological drivers of cancer and are pursuing additional opportunities for pipeline expansion through academic and biopharmaceutical collaborations, providing patients with new potential solutions to not just treat but cure cancer. It was founded in 2018 and headquartered in San Diego, California.
ERASCA
Industry:
Biotechnology Life Science
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.erasca.com
Total Employee:
11+
Status:
Active
Contact:
(858) 465-6511
Total Funding:
300 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Google Tag Manager WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx
Similar Organizations
Sana Biotechnology
Sana Biotechnology is a developer of engineered cells intended to be used as medicine for patients.
Current Advisors List
Board_member
2019-06-01
Current Employees Featured
Jonathan Lim Chairman, CEO and Co-Founder @ Erasca
Chairman, CEO and Co-Founder
2018-10-01
David Chacko Chief Financial Officer @ Erasca
Chief Financial Officer
2021-01-01
Wei Lin Chief Medical Officer @ Erasca
Chief Medical Officer
2021-01-01
Robert Shoemaker Senior Vice President of Research @ Erasca
Senior Vice President of Research
Karen Gilmore VP, Finance @ Erasca
VP, Finance
Lisa Schechet Senior Director, Clinical Operations @ Erasca
Senior Director, Clinical Operations
2020-10-01
Lisa Tesvich-Bonora Chief People Officer @ Erasca
Chief People Officer
Wendie Konold Sr Manager, Human Resources @ Erasca
Sr Manager, Human Resources
2021-03-01
Les Brail VP, Clinical Development @ Erasca
VP, Clinical Development
Gary Yeung Chief Operating & Financial Officer @ Erasca
Chief Operating & Financial Officer
2019-01-01
Founder
Stock Details
Investors List
Partner Fund Management
Partner Fund Management investment in Series B - Erasca
OrbiMed
OrbiMed investment in Series B - Erasca
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Erasca
City Hill Ventures
City Hill Ventures investment in Series B - Erasca
EDBI
EDBI investment in Series B - Erasca
Invus
Invus investment in Series B - Erasca
Terra Magnum Capital Partners (""""TMCP"""")""
Terra Magnum Capital Partners (""""TMCP"""")"" investment in Series B - Erasca
Colt Ventures
Colt Ventures investment in Series B - Erasca
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Erasca
LifeSci Venture Partners
LifeSci Venture Partners investment in Series B - Erasca
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-18 | Erasca Strengthens Leadership Team with Two Key Executive Appointments |
Official Site Inspections
http://www.erasca.com Semrush global rank: 4.01 M Semrush visits lastest month: 3.09 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Erasca"
Careers - Erasca
Are you ready to become a part of our exceptional, mission-driven organization? Core Value. Key Ingredient. Committed to erasing cancer in patients. Mission-Driven: We are ... Jonathan is …See details»
About - Erasca
At erasca, our name is our mission:to erase cancer. We are a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for RAS- and MAPK pathway-driven cancers. …See details»
Erasca - Crunchbase Company Profile & Funding
Erasca develops oncology drugs intended to provide precision oncology options. The company's drugs are being developed through multiple discovery …See details»
Erasca, Inc. | LinkedIn
Erasca, Inc. Biotechnology Research San Diego, California 6,606 followers Our mission at Erasca is embedded in our name: To erase cancer.See details»
Investors – Erasca
Corporate overview. Erasca is a clinical-stage, precision oncology company with a bold mission—to erase cancer. We are focused on the discovery, development and …See details»
Erasca, Inc. Employee Directory, Headcount & Staff | LeadIQ
Frequently Asked Questions What is Erasca, Inc. known for? Erasca, Inc. was founded in 2018 operates in the Biotechnology Research industry.The company's main headquarters is located …See details»
Erasca Strengthens Leadership Team with Two Key Executive …
Jan 18, 2022 “I am thrilled to welcome Lisa to the Erasca family. With over two decades of experience in creating collaborative and engaging environments where employees can thrive, …See details»
Jobs at Erasca
Our Mission at Erasca is embedded in our name: To erase cancer. Energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed …See details»
Erasca Strengthens Clinical and Commercial Leadership with Three …
John Lo, Ph.D., appointed as Senior Commercial Advisor and member of Erasca’s newly expanded Research, Development, and Commercial Advisory Board. ... where he successfully …See details»
Erasca Announces Exclusive Worldwide License for Pan-RAF …
Dec 9, 2022 Erasca to host conference call and webcast today at 8:30 am ET. SAN DIEGO, Dec. 09, 2022 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage …See details»
People - Erasca
Prior to Erasca, she was one of the first 20 employees at Myovant Sciences, serving as Vice President of Pharmaceutical Operations and Development, where she built the CMC …See details»
Erasca Reports Fourth Quarter and Full Year 2024 Business …
2 days ago Erasca, Inc. Potentially best-in-class RAS-targeting franchise advancing with both ERAS-0015 and ERAS-4001 expected to enter the clinic in 2025See details»
Erasca : Corporate Presentation March 2025 - MarketScreener.com
2 days ago Via Erasca Ventures, we made an equity investment into Affini-T Therapeutics, which is developing TCR T-cell therapies against KRAS G12V, KRAS G12D, and KRAS …See details»
Erasca Mission, Values, Culture & Jobs - Teal_HQ
Erasca was founded in 2018 and is headquartered in San Diego, California. Mission. Erasca's core mission is centered around eradicating cancer by revolutionizing the way it is detected, …See details»
Erasca Expands Leadership Team with Key Appointments
May 27, 2021 Prior to Erasca, she was one of the first 20 employees at Myovant Sciences, serving as vice president of pharmaceutical operations and development, where she built the …See details»
Erasca Cuts 18% and Replaces KRAS Program with New Anti …
Erasca, a San Diego-based biotechnology firm specializing in cancer treatments targeting the RAS/MAPK pathway, has announced a significant restructuring of its operations. This includes …See details»
Erasca Announces Publication of Promising Clinical Data …
Apr 25, 2023 Erasca cautions you that statements contained in this press release regarding matters that are not historical facts are forward-looking statements. The forward-looking …See details»
Erasca: New Focus After Restructuring, But Need More …
Sep 30, 2024 Erasca has a history of abandoning programs and restructuring. Bottom line. I checked out ERAS because of its decent market cap and cash balance and its focus on late …See details»
Erasca Reports Fourth Quarter and Full Year 2024 Business …
3 days ago Erasca also recorded $22.5 million of in-process R&D expense during the year ended December 31, 2024 for upfront payments under Erasca’s ERAS-0015 and ERAS-4001 …See details»
Erasca Number of Employees - Stock Analysis
Dec 31, 2023 Erasca had 126 employees as of December 31, 2023. The number of employees decreased by 3 or -2.33% compared to the previous year. Employees 126. Change (1Y) -3. …See details»